checkAd

     157  0 Kommentare G1 Therapeutics Announces Appointment of Monica Thomas as General Counsel

    The Company Also Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) in Conjunction with the Appointment

    RESEARCH TRIANGLE PARK, N.C., May 22, 2023 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced the appointment of Monica Thomas as its General Counsel and Chief Compliance Officer. Mrs. Thomas replaces Stillman Hanson who departed the Company in May 2023.

    “G1 is in the midst of an important period in our evolution, as we evolve our commercial and clinical capabilities to maximize the future value of COSELA (trilaciclib) and ensure that all appropriate patients may have access to this important drug,” said Jack Bailey, Chief Executive Officer of G1 Therapeutics. “As we do so, it is essential that we maintain our fundamental focus on excellence in compliance, governance, and agency engagement. Monica’s deep sector experience across all such areas will be important to our continued success as an emerging biotechnology company.”

    Lesen Sie auch

    Mrs. Thomas brings nearly two decades of leadership experience in securities filings and corporate governance, global regulatory engagement, and all aspects of legal support for commercialization of drug products/biologics. Mrs. Thomas has joined G1 after serving as Head of Corporate Legal and Assistant Corporate Secretary at Radius Health where she advised senior executives and the Board of Directors, established a framework for successful commercialization in Japan, and oversaw the resolution of costly litigation. Previously, she was Associate General Counsel for UCB, Inc. where she supported the launch of a reimagined Rare Disease organization. Prior to that, she held numerous leadership roles over 12 years with GlaxoSmithKline, serving as legal lead on the launch of a first-in-industry TV advertisement for HIV medication, the commercialization of medications and biologics across multiple disease states, and the standardization of contracting policies and procedures for Global Manufacturing Supply. Mrs. Thomas also served as a Corporate Securities Associate with Smith Anderson, one of North Carolina’s largest business law firms. She is admitted to the North Carolina state bar and earned a Juris Doctorate degree from North Carolina Central University School of Law and a Bachelor of Arts degree from Duke University.

    Seite 1 von 3


    Diskutieren Sie über die enthaltenen Werte


    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    G1 Therapeutics Announces Appointment of Monica Thomas as General Counsel The Company Also Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) in Conjunction with the AppointmentRESEARCH TRIANGLE PARK, N.C., May 22, 2023 (GLOBE NEWSWIRE) - G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology …